Before You Sign a Longevity Clinic Franchise: Which Lawyers You Need and When

Franchise counsel, healthcare-regulatory counsel, and general corporate work are three different jobs at three different stages, here is how to sequence them.

By Noah Green CPA CFE

Plain-English disclaimer: This article is for business diligence and educational purposes. It is not legal, tax, medical, or investment advice. Legal requirements vary by state and by transaction. Retain qualified counsel for your specific situation.

The Short Version

Most franchise buyers hire one lawyer and call it done. For a longevity clinic franchise, hormone therapy, weight-loss, peptide, or med spa, one lawyer is not enough, and the gap is not about effort. It is about subject matter.

A longevity clinic franchise investor needs at least two different legal specialists in sequence: a franchise attorney to review the franchisor’s disclosure and agreement, and a healthcare-regulatory attorney to review the clinic’s legal structure for the state where it will operate. A third lane, general corporate counsel, handles entity formation and business contracts. Each specialty has a defined job. None of them substitute for the others.

Treating them as interchangeable creates a gap at the worst possible moment, after signing and before opening, when the investor is committed and the structure has to actually work.

Why These Are Three Different Specialties

Franchise law is the law of the disclosure document, the franchise agreement, and the relationship between franchisor and franchisee. A franchise attorney reviews the Franchise Disclosure Document (FDD, the franchisor’s official disclosure package, required by federal rule to be delivered at least 14 days before signing or paying), identifies red flags in how earnings claims, territory rights, and exit terms are presented, and evaluates the franchise agreement’s obligations, costs, and controls. A franchise attorney is not trained, and typically not licensed, to opine on whether a Nevada clinic structure violates the Corporate Practice of Medicine doctrine (CPOM, the rule that a lay business should not own or control the practice of medicine), whether a management-services agreement’s fee structure creates anti-kickback exposure (anti-kickback laws prohibit compensation arrangements that reward medical referrals or prescriptions), or whether the medical director arrangement satisfies state medical board requirements.

Healthcare-regulatory law is a different specialty. A healthcare-regulatory attorney analyzes who controls the medical practice, how the clinical and business entities are structured, whether supervision requirements are met, what telehealth licensing requires for the patient’s state, whether compensation arrangements create fee-splitting or kickback risk, and whether drug sourcing, compounding, and advertising are compliant. In Nevada, that means working with professional-entity statutes, physician-licensing and discipline rules, medical-board delegation requirements, pharmacy-board rules, and federal guidance from the HHS Office of Inspector General, the Centers for Medicare and Medicaid Services, and the FTC. A healthcare-regulatory attorney is not the resource for reviewing the FDD’s franchisee contact list or evaluating whether a pattern of earnings misrepresentation runs through the franchisor’s public record.

General corporate counsel handles entity formation, operating agreements, cap-table structure, employment agreements, and vendor contracts. This role is real and necessary, but it does not substitute for either specialty. Do not ask a general corporate attorney to opine on CPOM. Do not ask a franchise attorney to draft the management-services agreement between the professional clinical entity and the management company. The specialties do not overlap.

The investor who skips healthcare counsel and relies only on franchise counsel signs a clean-looking franchise agreement for a clinic that may not be legally structured to operate. The investor who skips franchise counsel and relies only on healthcare counsel may have a compliant clinic entity and a defective franchise agreement. Both gaps cost money.

The Transaction Timeline

Legal spend should track risk, not convention. The practical sequence has three stages. The investor who understands what is supposed to happen at each stage, and which specialist leads it, avoids the two most common mistakes: deferring legal review until after signing, and hiring the wrong specialty for the job.

Stage 1, Before You Sign: FDD Review and Pre-Diligence

Franchise counsel leads. When the buyer receives the FDD, the 14-day clock starts. Franchise counsel reviews all 23 items in the disclosure document. The critical sections are:

Item 19, the financial performance representation section (a franchisor may, but is not required to, share actual earnings data from existing outlets; if one is provided, the buyer should require written substantiation for every number)
Item 20, the franchisee contact list (the buyer’s access to current, former, closed, and transferred operators)
Item 3, the franchisor’s litigation and arbitration history
Item 7, estimated startup costs
The franchise agreement itself, including territory rights, transfer costs, noncompete scope, and exit terms

Healthcare-regulatory counsel scopes at this stage, not after. For a longevity clinic, the regulatory structure question should be raised during FDD review, not after signing. The reason: a franchisor’s brand standards may embed assumptions about clinical control, medical director arrangements, or telehealth delivery that conflict with the state’s CPOM rules. If the structure cannot be made compliant in the buyer’s target state, that is a pre-signing problem, not a post-signing one.

The question to put to healthcare counsel at this stage is narrow: does the franchise system’s model, as described in the FDD, present a structure that can be set up compliantly in the target state, and what legal work will be required at Stage 2?

Corporate counsel is minimal at this stage. If the buyer is evaluating entity options, a brief conversation makes sense. The heavy lifting comes later.

Stage 2, Between Signing and Opening: Entity Structure and Setup

Healthcare-regulatory counsel leads. This is the stage where the two-specialty problem becomes urgent. The investor must set up:

the professional entity (Professional Corporation, Professional LLC, or equivalent) that will own and operate the clinical practice, this entity must be owned and controlled by a licensed physician, not the investor directly, unless the investor is also a licensed physician
the Management Services Organization (MSO, the investor’s business entity that provides nonclinical services: space, equipment, marketing, scheduling, bookkeeping, payroll administration)
the management-services agreement between the MSO and the professional entity, this document must be reviewed for fee-splitting risk (management fees cannot function as a percentage-of-medical-revenue split), and for whether it preserves real clinical authority with the professional entity or surrenders it to the MSO
the medical director agreement, the physician must have the license, time, authority, and independence to supervise clinical services, not just sign forms
clinical protocols, delegation frameworks, and supervision documentation
telehealth vendor contracts, if the clinic model uses remote prescribers or remote supervision, each provider must be licensed in the state where the patient is located

Franchise counsel re-enters at Stage 2 with a specific job: check whether the franchisor’s required brand standards conflict with what healthcare-regulatory counsel says the state allows. If the franchise agreement requires the investor to follow clinical protocols the franchisor sets, that may constitute impermissible lay control of medicine. Catching this conflict at Stage 2, before buildout, before the medical director contract is signed, before the management-services agreement is finalized, is far cheaper than catching it after the clinic is open.

Corporate counsel handles entity formation documents, operating agreements, cap-table structure, and employment agreements for nonclinical staff.

Stage 3, Ongoing Operations: Compliance and Risk Management

Healthcare-regulatory counsel monitors the clinic through its lifecycle: license renewals and license-status checks on clinical staff, medical-board rule changes that affect delegation or supervision, changes to drug-sourcing rules (GLP-1 compounding regulations, peptide sourcing requirements, and controlled-substance DEA rules have all shifted in recent years), and advertising review. Every marketing claim that describes a medical outcome is subject to FTC health-products guidance and state consumer-protection rules.

Franchise counsel handles mid-term issues: renewal negotiations, transfer requirements, territorial disputes, and exit. The franchise agreement’s exit terms often look different after a few years of operations than they did on paper at signing.

Corporate counsel handles general governance, vendor contract renewals, and employment matters.

The Franchise Attorney’s Job

A franchise attorney’s core deliverable is the FDD review. The FDD is a 23-item document required by the FTC Franchise Rule. Not every item carries the same weight, but several require close attention for a longevity clinic buyer:

Item 19 (earnings claims): If a financial performance representation is provided, the buyer needs written substantiation. If one is not provided, the buyer should ask why. Public FTC enforcement cases across this series, Burgerim, Xponential Fitness, Minuteman Press, and Jani-King prominently, document earnings-information problems in recurring forms: oral claims made outside Item 19, affiliate-owned-outlet data that excluded franchisee performance, and top-line revenue figures that obscured the actual margin structure.

Item 20 (franchisee contacts): The buyer’s best due-diligence tool. The list should include current franchisees, former franchisees, and, critically, outlets that were signed but never opened. The franchise attorney ensures the buyer actually calls enough contacts and asks the right questions: ramp time, support quality, opening delays, working-capital burn, and whether advertised economics matched operations.

Item 3 (litigation): The franchise attorney checks whether the franchisor, its principals, or its predecessors have litigation, arbitration, regulatory, or bankruptcy history that suggests a pattern.

The agreement itself: Territory exclusivity language that sounds protective in the pitch may contain carve-outs in the fine print. Exit costs, transfer fees, training fees, noncompete terms, often only matter when the investor needs them. The franchise attorney’s job is to make those terms visible before signing.

The nine red flags that appear across the public FTC franchise-fraud case record, oral earnings claims outside Item 19, gross sales presented as net profit, compressed opening timelines, paid-but-never-opened outlet counts, impaired Item 20 access, refund promises that do not match documents, label games, missing executive history, and hidden exit costs, are the franchise attorney’s working checklist. A buyer who understands these patterns before the FDD review is a better client for that attorney and gets more value from the engagement.

FTC franchise-enforcement snapshot. The public record gives a prospective buyer concrete patterns to test for. Each of these is examined in full in our Case Studies series:

Case	Year	FTC outcome	Core red flag
Burgerim	2022 to 24	\$7.75M civil penalty + \$48.5M redress (entity judgment); founder banned from franchise sales	Oral earnings claims; paid-but-never-opened
Xponential Fitness	2026	\$17M franchisee redress (settlement)	Opening-timeline compression; Item 20 gaps
Qargo Coffee	2024	\$1.3M judgment (suspended to ~\$30k)	“License” relabeling; opening delays
Minuteman Press	1998	\$3.47M consumer redress (after a court finding)	Oral earnings vs. a written no-claims disclaimer
Tutor Time	1996	\$220k civil penalty (settlement)	Overstated earnings; understated opening time
Jani-King	1995	\$100k civil penalty (settlement)	Gross billings presented like net income

Minuteman Press was decided by a court after trial; the others resolved by settlement, in which the defendants neither admitted nor denied the allegations. The figures are from the FTC orders and judgments.

Franchise counsel pre-signing checklist. Before the FDD review is complete and before signing or paying anything, confirm answers to these questions with franchise counsel:

Did I receive the Franchise Disclosure Document at least 14 days before signing or paying, with a dated receipt?
Are all financial performance claims in Item 19, with written substantiation available for every number?
How many franchisees have signed agreements but never opened, and what is the median time from signing to opening?
Do refund, territory, transfer, and exit promises in the sales conversation match the actual franchise agreement language?
Have counsel searched the franchisor’s principals for litigation, bankruptcy, prior franchise systems, and regulatory enforcement history?

The Healthcare-Regulatory Attorney’s Job

The healthcare-regulatory attorney’s job starts with one question: who controls the medicine?

For a longevity clinic, the answer has to be a licensed physician or physician-owned entity, not the investor, the franchise brand, or the management company. That is what the Corporate Practice of Medicine doctrine requires. In Nevada, the public legal starting points are NRS Chapter 89 (professional entities) and NRS Chapter 630 (physician licensing and discipline).

The two-entity Friendly-PC plus MSO structure is the standard compliance approach. The professional entity, owned by a licensed physician, handles clinical services. The MSO, which the investor may own, handles nonclinical business services. The two entities are linked by a management-services agreement. The structure works only if the clinical entity actually controls clinical care. Red flags that suggest it does not include: the MSO sets medical protocols without physician approval; the MSO controls hiring, firing, or compensation for clinical staff; the management fee is a percentage of medical revenue rather than a fixed, commercially reasonable service fee; the franchise brand standards override physician judgment on patient suitability or treatment.

The medical director agreement is a separate document that needs separate review. A salaried physician with no equity in the professional entity is not automatically a compliance problem. The diligence question is whether that physician has real authority, real time, a valid Nevada license, genuine independence from the business side, and documented supervision practices. NAC (Nevada Administrative Code) 630.810 covers physician delegation to medical assistants. The supervision requirements are specific and operational, not just paperwork.

Telehealth adds a layer. NRS 629.515 requires a provider at a distant site to hold a valid Nevada license, or otherwise qualify under Nevada law, before using telehealth to direct care, diagnose, treat, or prescribe for a Nevada patient. If the franchise model relies on out-of-state or network physicians for prescribing or supervision, each of them needs to qualify for Nevada patients.

Fee-splitting and anti-kickback risk runs through the economics. A percentage-of-revenue management fee, medical-director compensation tied to prescription volume, pharmacy or lab arrangements that reward referrals, and supplement commissions that flow back based on physician decisions are all risk categories. The healthcare-regulatory attorney reviews the compensation structure before it is finalized, not after revenue is running.

The drug, product, and advertising layer is the third operational area. GLP-1 compounding, peptide sourcing, HGH, injectables, and IV therapies each carry their own FDA, DEA, pharmacy-board, and medical-board requirements. FTC health-products guidance requires health claims to be truthful, not misleading, and supported by competent evidence. Advertising that promises medical outcomes the clinic cannot substantiate is a compliance problem that survives disclosure review.

What To Ask Each Lawyer Before You Hire Them

Franchise counsel

Have you reviewed FDDs for longevity clinics, hormone-therapy clinics, or med spas?
How many Item 19 financial performance representations have you analyzed in the health and wellness sector?
Can you identify the territory exclusivity, transfer, and exit terms that most often surprise buyers in this space?
Have you run background searches on franchise principals and cross-referenced them against public FTC and state enforcement records?

Healthcare-regulatory counsel

Are you licensed to practice in the state where the clinic will operate?
Do you regularly structure and review Professional Corporation or PLLC (Professional Limited Liability Company) plus MSO arrangements for medical practices?
Have you reviewed a franchise system’s brand standards for CPOM conflicts with the state’s requirements?
Do you handle GLP-1, peptide, hormone, or controlled-substance sourcing questions?
Have you reviewed advertising and marketing materials for clinical claims under FTC and state consumer-protection standards?
What is your approach to medical director supervision documentation and delegation frameworks?

Corporate counsel

Have you handled entity formation alongside a healthcare-regulatory attorney for a clinic or MSO structure?
Do you understand the cap-table implications of a professional-entity requirement that bars non-physician ownership?
Can you coordinate operating-agreement drafts with the management-services agreement your healthcare-regulatory counsel is reviewing?

The Sequencing Summary

Stage	Franchise Counsel	Healthcare-Regulatory Counsel	Corporate Counsel
Pre-signing (FDD review)	Leads	Scope review only	Optional
Entity setup (pre-opening)	Brand-standards conflict check	Leads	Entity formation
Ongoing operations	Renewal / exit	Compliance	General governance

The investor’s legal cost is lowest when each specialty is engaged in the right order. Franchise counsel who catches a disclosure problem before signing is inexpensive. Franchise counsel who catches the same problem after it produces a lawsuit is not. Healthcare-regulatory counsel who structures the entities correctly before buildout avoids a restructuring problem that arises under operating pressure. The sequence is not a luxury. It is the investment.

SPP Bottom Line

The longevity clinic franchise investor’s legal budget is not wasted when it covers all three specialties in sequence. The waste happens in two specific ways: when one specialty is asked to cover another’s job, and when legal review is deferred until after signing.

The structure question, who controls the medicine, and is the two-entity arrangement set up correctly for the state, precedes the concept question, the revenue model, and the brand decision. The franchise-agreement question, are the disclosure document, territory rights, earnings claims, and exit terms what they appear to be, also precedes the commitment.

Both questions have clear answers, with the right specialists at the right stage.

The cost of getting it wrong is not abstract. The ACFE Report to the Nations (2024) finds organizations lose an estimated 5% of revenue to fraud each year, with a median loss of \$145,000 and a typical scheme running about 12 months before detection. The franchise-buyer version of that lesson is simple: the cheapest fraud to survive is the one you decline before signing, and the way you decline it is independent verification, not trust in the sales story.

Primary Sources

A companion source register of public authorities is maintained separately.